Additionally, we found that activation of TGFβ/SMAD4 signaling modestly reduced tumor cell expression of PD-L1 in vitro; however, SMAD4 and PD-L1 positively correlated in PDAC patient samples. The gene discussed is SMAD4; the disease is neoplasm.